every 3 months in patients whose therapy has changed and/or who are not meeting glycemic goals
It might be safe to use GLP-1 [receptor agonists] in the preoperative period, Qais AbuHasan , MD, research fellow at the Indiana University School of Medicine, who presented the findings, said in the release
Abstract Introduction Clinical trials have demonstrated greater glycemic control and weight loss with once-weekly (OW) semaglutide versus other anti-diabetes medications, including sodium-glucose co-transporter 2 inhibitors (SGLT2is) in adults with type 2 diabetes (T2D), yet real-world evidence is limited
Bilateral injections of AAV vectors encoding for stimulatory (AAV8-hSyn-DIO-hM3Dq-mCherry, Addgene, 44361-AAV8) or inhibitory (AAV8-hSyn-dF-HA-KORD-IRES-mCitrine, Addgene, 65417-AAV8) Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) were then performed in the OB (A/P: +4.8 mm from bregma, M/L: 1 mm and D/V: 1.7 mm from brain surface) at a rate of 0.125 L/min for 4 min, on Glp1r -Cre RD and WD mice
It is important to monitor your symptoms if you change to oral B12